|Bid||8.55 x 2200|
|Ask||8.78 x 2200|
|Day's Range||8.56 - 8.76|
|52 Week Range||6.25 - 13.76|
|Beta (5Y Monthly)||1.50|
|PE Ratio (TTM)||2,180.00|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 27, 2017|
|1y Target Est||12.19|
Johnson & Johnson is hoping to tackle the new form of coronavirus with a vaccine, but the pharma giant is still facing litigation challenges. Is JNJ stock a buy right now?
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA) between October 29, 2015 and August 18, 2020, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Teva investors under the federal securities laws.
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited.